Prevalence of polycystic ovarian syndrome among adolescents and young women in India

被引:11
作者
Mehreen, Thaharullah Shah [1 ]
Ranjani, Harish [1 ]
Kamalesh, Rajan [2 ]
Ram, Uma [3 ]
Anjana, Ranjit Mohan [4 ]
Mohan, Viswanathan [4 ]
机构
[1] Madras Diabet Res Fdn, Dept Translat Res, Chennai, Tamil Nadu, India
[2] Madras Diabet Res Fdn, Dept Res Operat, Chennai, Tamil Nadu, India
[3] Seethapathy Clin & Hosp, Chennai, Tamil Nadu, India
[4] Madras Diabet Res Fdn, Dept Diabetol, Chennai, Tamil Nadu, India
关键词
Adolescence; India; PCOS; prevalence; ANDROGEN EXCESS; RISK; INSULIN; PCOS; PHENOTYPE; WHITE;
D O I
10.4103/JOD.JOD_105_20
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: There is little epidemiological data from India on the prevalence of polycystic ovarian syndrome (PCOS). The objectives of the present study were to estimate the prevalence of PCOS using different criteria among adolescents and young women and to evaluate risk factors associated with PCOS. Materials and Methods: A total of 518 participants, adolescents (12-17 years, n = 246) and young women (18-30 years, n = 272), were recruited. Participants who were overweight and having menstrual disorders or biochemical abnormalities were invited for ultrasonographic examination. A standardized questionnaire assessed the regularity of menstrual cycles, body hair growth, skin, body weight, sleep, and androgen excess. The ovarian volume and follicular size were assessed transabdominally. Prevalence of PCOS was assessed by the Rotterdam, AE-PCOS, and NIH criteria. Results: The mean age of participants with PCOS was 19.7 +/- 4.2 years and those without PCOS was 18.4 +/- 4.2 years. Mean body weight, body fat %, body mass index, waist circumference, systolic and diastolic blood pressures, and fasting insulin were significantly higher in the PCOS group. Prevalence of polycystic ovaries on ultrasonography was observed in 78.6% of the women with PCOS as against 5% in women without PCOS. Obesity (odds ratio (OR): 3.09, 95% confidence interval (CI): 1.32-7.21), insulin resistance (OR: 2.12, 95% CI: 1.12-4.0), and hypertension (OR: 4.46, 95% CI: 1.52-13.06) were significantly associated with PCOS (P < 0.05). The overall prevalence of PCOS was highest with 8.1% according to the Rotterdam criteria followed by AE-PCOS (2.9%) and NIH (2.1%). Irrespective of the criterion used, the prevalence increased with age. Conclusion: There is a high prevalence of PCOS in urban India, which emphasizes the need for urgent preventive and control measures. Early diagnosis is therefore crucial in incorporating lifestyle and dietary modifications for weight reduction and better control of blood pressure at a younger age to further prevent long-term reproductive and metabolic disorders.
引用
收藏
页码:319 / 325
页数:7
相关论文
共 31 条
[1]   Criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: An Androgen Excess Society guideline [J].
Azziz, Ricardo ;
Carmina, Enrico ;
Dewailly, Didier ;
Diamanti-Kandarakis, Evanthia ;
Escobar-Morreale, Hector F. ;
Futterweit, Walter ;
Janssen, Onno E. ;
Legro, Richard S. ;
Norman, Robert J. ;
Taylor, Ann E. ;
Witchel, Selma F. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (11) :4237-4245
[2]   Urban Rural Comparisons of Polycystic Ovary Syndrome Burden among Adolescent Girls in a Hospital Setting in India [J].
Balaji, Swetha ;
Amadi, Chioma ;
Prasad, Satish ;
Kasav, Jyoti Bala ;
Upadhyay, Vandana ;
Singh, Awnish K. ;
Surapaneni, Krishna Mohan ;
Joshi, Ashish .
BIOMED RESEARCH INTERNATIONAL, 2015, 2015
[3]   Prevalence of polycystic ovary syndrome in a sample of Indigenous women in Darwin, Australia [J].
Boyle, Jacqueline A. ;
Cunningham, Joan ;
O'Dea, Kerin ;
Dunbar, Terry ;
Norman, Robert J. .
MEDICAL JOURNAL OF AUSTRALIA, 2012, 196 (01) :62-66
[4]   The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis [J].
Bozdag, Gurkan ;
Mumusoglu, Sezcan ;
Zengin, Dila ;
Karabulut, Erdem ;
Yildiz, Bulent Okan .
HUMAN REPRODUCTION, 2016, 31 (12) :2841-2855
[5]   Lifestyle and Behavioral Management of Polycystic Ovary Syndrome [J].
Brennan, Leah ;
Teede, Helena ;
Skouteris, Helen ;
Linardon, Jake ;
Hill, Briony ;
Moran, Lisa .
JOURNAL OF WOMENS HEALTH, 2017, 26 (08) :836-848
[6]  
Carmina E, 2004, Minerva Ginecol, V56, P1
[7]  
Chhabra S., 2019, EC Endocrinol. Metabol. Res., V4, P91, DOI [10.4103/JOD.JOD_105_20, DOI 10.4103/JOD.JOD_105_20]
[8]   The prevalence of polycystic ovary syndrome in reproductive-aged women of different ethnicity: a systematic review and meta-analysis [J].
Ding, Tao ;
Hardiman, Paul J. ;
Petersen, Irene ;
Wang, Fang-Fang ;
Qu, Fan ;
Baio, Gianluca .
ONCOTARGET, 2017, 8 (56) :96351-96358
[9]   Screening women with polycystic ovary syndrome for metabolic syndrome [J].
Dokras, A ;
Bochner, M ;
Hollinrake, E ;
Markham, S ;
VanVoorhis, B ;
Jagasia, DH .
OBSTETRICS AND GYNECOLOGY, 2005, 106 (01) :131-137
[10]   Cancer risk and PCOS [J].
Dumesic, Daniel A. ;
Lobo, Rogerio A. .
STEROIDS, 2013, 78 (08) :782-785